Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 1
1978 1
1980 1
1981 3
1982 3
1983 1
1984 1
1986 3
1987 3
1988 6
1989 8
1990 5
1991 8
1992 10
1993 13
1994 9
1995 7
1996 7
1997 13
1998 9
1999 13
2000 12
2001 16
2002 15
2003 15
2004 20
2005 19
2006 15
2007 21
2008 19
2009 25
2010 16
2011 26
2012 23
2013 24
2014 30
2015 33
2016 30
2017 28
2018 44
2019 40
2020 54
2021 59
2022 43
2023 34
2024 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

714 results

Results by year

Filters applied: . Clear all
Page 1
American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Nutrition Screening and Therapy Within a Surgical Enhanced Recovery Pathway.
Wischmeyer PE, Carli F, Evans DC, Guilbert S, Kozar R, Pryor A, Thiele RH, Everett S, Grocott M, Gan TJ, Shaw AD, Thacker JKM, Miller TE, Hedrick TL, McEvoy MD, Mythen MG, Bergamaschi R, Gupta R, Holubar SD, Senagore AJ, Abola RE, Bennett-Guerrero E, Kent ML, Feldman LS, Fiore JF Jr; Perioperative Quality Initiative (POQI) 2 Workgroup. Wischmeyer PE, et al. Among authors: bergamaschi r. Anesth Analg. 2018 Jun;126(6):1883-1895. doi: 10.1213/ANE.0000000000002743. Anesth Analg. 2018. PMID: 29369092 Review.
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
He A, Merkel B, Brown JWL, Zhovits Ryerson L, Kister I, Malpas CB, Sharmin S, Horakova D, Kubala Havrdova E, Spelman T, Izquierdo G, Eichau S, Trojano M, Lugaresi A, Hupperts R, Sola P, Ferraro D, Lycke J, Grand'Maison F, Prat A, Girard M, Duquette P, Larochelle C, Svenningsson A, Petersen T, Grammond P, Granella F, Van Pesch V, Bergamaschi R, McGuigan C, Coles A, Hillert J, Piehl F, Butzkueven H, Kalincik T; MSBase study group. He A, et al. Among authors: bergamaschi r. Lancet Neurol. 2020 Apr;19(4):307-316. doi: 10.1016/S1474-4422(20)30067-3. Epub 2020 Mar 18. Lancet Neurol. 2020. PMID: 32199096
Nullius in Verba.
Bergamaschi R, Tonelli F. Bergamaschi R, et al. Updates Surg. 2022 Apr;74(2):387-389. doi: 10.1007/s13304-022-01260-2. Epub 2022 Mar 8. Updates Surg. 2022. PMID: 35258840 No abstract available.
Multiple Sclerosis Progression and Relapse Activity in Children.
Iaffaldano P, Portaccio E, Lucisano G, Simone M, Manni A, Guerra T, Paolicelli D, Betti M, De Meo E, Pastò L, Razzolini L, Rocca MA, Ferrè L, Brescia Morra V, Patti F, Zaffaroni M, Gasperini C, De Luca G, Ferraro D, Granella F, Pozzilli C, Romano S, Gallo P, Bergamaschi R, Coniglio MG, Lus G, Vianello M, Banfi P, Lugaresi A, Totaro R, Spitaleri D, Cocco E, Di Palma F, Maimone D, Valentino P, Torri Clerici V, Protti A, Maniscalco GT, Salemi G, Pesci I, Aguglia U, Lepore V, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register. Iaffaldano P, et al. Among authors: bergamaschi r. JAMA Neurol. 2024 Jan 1;81(1):50-58. doi: 10.1001/jamaneurol.2023.4455. JAMA Neurol. 2024. PMID: 38010712 Free PMC article.
Hexahydrocannabinol on the Light Cannabis Market: The Latest "New" Entry.
Casati S, Rota P, Bergamaschi RF, Palmisano E, La Rocca P, Ravelli A, Angeli I, Minoli M, Roda G, Orioli M. Casati S, et al. Among authors: bergamaschi rf. Cannabis Cannabinoid Res. 2024 Apr;9(2):622-628. doi: 10.1089/can.2022.0253. Epub 2022 Nov 23. Cannabis Cannabinoid Res. 2024. PMID: 36445181 Free article.
Watch and wait: staying the course?
Bergamaschi R, Bhatti S. Bergamaschi R, et al. Updates Surg. 2023 Sep;75(6):1379-1381. doi: 10.1007/s13304-023-01529-0. Epub 2023 May 10. Updates Surg. 2023. PMID: 37162638 No abstract available.
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. Brown JWL, et al. Among authors: bergamaschi r. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588. JAMA. 2019. PMID: 30644981 Free PMC article.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Portaccio E, Bellinvia A, Fonderico M, Pastò L, Razzolini L, Totaro R, Spitaleri D, Lugaresi A, Cocco E, Onofrj M, Di Palma F, Patti F, Maimone D, Valentino P, Confalonieri P, Protti A, Sola P, Lus G, Maniscalco GT, Brescia Morra V, Salemi G, Granella F, Pesci I, Bergamaschi R, Aguglia U, Vianello M, Simone M, Lepore V, Iaffaldano P, Filippi M, Trojano M, Amato MP. Portaccio E, et al. Among authors: bergamaschi r. Brain. 2022 Aug 27;145(8):2796-2805. doi: 10.1093/brain/awac111. Brain. 2022. PMID: 35325059
Innovations and bandwagons.
Gachabayov M, Bergamaschi R. Gachabayov M, et al. Among authors: bergamaschi r. Colorectal Dis. 2019 Dec;21(12):1353. doi: 10.1111/codi.14892. Colorectal Dis. 2019. PMID: 31788921 No abstract available.
714 results